Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.54 AUD | 0.00% | +9.09% | +163.41% |
May. 29 | Euroz Hartleys Adjusts Dimerix’s Price Target to AU$0.86 From AU$0.80, Keeps at Speculative Buy | MT |
May. 27 | Dimerix Signs License Deal for Kidney Disease Medication in the Middle East | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+163.41% | 179M | |
+55.55% | 59.34B | |
+43.17% | 40.24B | |
-4.71% | 39.88B | |
-5.56% | 28.55B | |
+13.76% | 27.26B | |
-22.00% | 19.23B | |
+31.50% | 12.61B | |
+2.16% | 12.49B | |
+25.70% | 12.28B |
- Stock Market
- Equities
- DXB Stock
- News Dimerix Limited
- Dimerix Secures Conditional US FDA Clearance for Kidney Medication Brand Name